Skip to content

Aquestive Therapeutics

US · AQST #3650 by market cap Listed 2018
3.46 -0.25 -6.61%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Quant vs Street three independent views, side by side

StockVane factor grade
D+
Momentum strategy signal
Strong Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 4 analysts

Buy
Avg price target 9.25 +167.3%
Price target rangecurrent 3.46
Low6.00
Avg9.25
High11.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-09 H.C. Wainwright -- Buy 10.00
2026-11-05 Leerink Partners -- Buy 11.00
2026-10-16 H.C. Wainwright -- Buy 10.00
2026-10-15 H.C. Wainwright -- Buy 10.00
2026-09-21 H.C. Wainwright -- Buy 10.00
2026-09-17 LifeSci Capital -- Buy 10.00
2026-09-17 Lake Street -- Buy 6.00
2026-08-24 H.C. Wainwright -- Buy 10.00
2026-08-13 LifeSci Capital -- Buy 10.00
2026-08-10 LifeSci Capital -- Buy 10.00
2026-08-10 Lake Street -- Buy 6.00
2026-06-25 Cantor Fitzgerald -- Buy 11.00
2026-06-25 Chardan Capital -- Buy 8.00
2026-06-25 LifeSci Capital -- Buy 9.00
2026-05-15 LifeSci Capital -- Buy 9.00
2026-05-15 Piper Sandler -- Buy 8.00
2026-05-15 Leerink Partners -- Buy 9.00
2026-05-15 Lake Street -- Buy 6.00
2026-05-15 Oppenheimer -- Buy 8.00
2026-05-14 A. G. P. -- Buy 9.00
2026-04-24 Oppenheimer -- Buy 8.00
2026-03-30 LifeSci Capital -- Buy 9.00
2026-03-30 Lake Street -- Buy 6.00
2026-03-09 H.C. Wainwright -- Buy 10.00
2026-03-09 Oppenheimer -- Buy 8.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-03 After close ±14.82% -2.06% (in line)
2026/Q2 2026-08-11 After close ±14.74% -4.08% (in line)
2026/Q1 2026-05-13 After close ±9.08% +14.53% (beat)
2025/Q4 2026-03-04 After close ±16.59% -2.52% (in line)
2025/Q3 2025-11-05 After close ±15.71% +2.17% (in line)
2025/Q2 2025-08-11 After close ±34.59% -2.07% (in line)
2025/Q1 2025-05-12 After close ±18.60% -19.65% (beat)
2024/Q4 2025-03-05 After close ±24.37% -7.53% (in line)
2024/Q3 2024-11-04 After close ±23.30% -7.67% (in line)
2024/Q2 2024-08-06 After close ±17.32% +0.88% (in line)
2024/Q1 2024-05-07 After close ±20.33% -8.73% (in line)
2023/Q4 2024-03-05 -- ±50.00% +20.05% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:02:37 · For reference only, not investment advice and not tailored to your situation.

Aquestive Therapeutics discussion 0 comments

Add a comment